Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Dumping Lantheus Holdings Inc (LNTH)

Page 1 of 2

Before we spend days researching a stock idea we’d like to take a look at how hedge funds and billionaire investors recently traded that stock. S&P 500 Index returned about 5.2% during the last 12 months ending October 30, 2015. Less than 49% of the stocks in the index outperformed the index. This means you (or a monkey throwing a dart) have less than an even chance of beating the market by randomly picking a stock. On the other hand, the top 30 S&P 500 stocks among hedge funds at the end of September 2014 had an average return of 9.5% during the same period. Sixty three percent of these 30 stocks outperformed the market. Hedge funds had bad stock picks like everyone else. Micron, which lost 50% over this period, was one of hedge funds’ 30 favorite S&P 500 stocks. Anadarko Petroleum was another failed stock pick which lost more than 26%. So, taking cues from hedge funds isn’t a foolproof strategy, but it seems to work on average. In this article, we will take a look at what hedge funds think about Lantheus Holdings Inc (NASDAQ:LNTH).

Is Lantheus Holdings a buy, sell, or hold? Prominent investors are in a pessimistic mood. The number of long hedge fund bets decreased by 1 in recent months. LNTH was in 4 hedge funds’ portfolios at the end of the third quarter of 2015. There were 5 hedge funds in our database with LNTH positions at the end of the previous quarter. At the end of this article we will also compare LNTH to other stocks, including Abeona Therapeutics Inc (NASDAQ:ABEO), Fenix Parts Inc (NASDAQ:FENX), and Planar Systems, Inc. (NASDAQ:PLNR) to get a better sense of its popularity.

Follow Lantheus Holdings Inc. (NASDAQ:LNTH)
Trade (NASDAQ:LNTH) Now!

In the eyes of most traders, hedge funds are seen as unimportant, outdated financial vehicles of years past. While there are over 8000 funds trading at present, Our experts choose to focus on the crème de la crème of this group, about 700 funds. Most estimates calculate that this group of people oversee the lion’s share of all hedge funds’ total capital, and by observing their inimitable investments, Insider Monkey has figured out several investment strategies that have historically outpaced Mr. Market. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, let’s take a look at the key action encompassing Lantheus Holdings Inc (NASDAQ:LNTH).

Hedge fund activity in Lantheus Holdings Inc (NASDAQ:LNTH)

Heading into Q4, a total of 4 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -20% from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were upping their holdings considerably (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Scopia Capital, managed by Matt Sirovich and Jeremy Mindich, holds the most valuable position in Lantheus Holdings Inc (NASDAQ:LNTH). Scopia Capital has a $8.3 million position in the stock, comprising 0.2% of its 13F portfolio. On Scopia Capital’s heels is Tamarack Capital Management, led by Justin John Ferayorni, holding a $2.6 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Remaining peers that are bullish contain Israel Englander’s Millennium Management and Ken Griffin’s Citadel Investment Group.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!